Kissei Pharmaceutical Co (JP:4547) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
KISSEI PHARMACEUTICAL CO., LTD. reported a solid financial performance for the first quarter ended June 30, 2024, with a 9.6% increase in net sales and a significant 32.2% rise in operating profit compared to the same period last year. The company also announced an optimistic full year forecast, expecting a 9.8% growth in net sales and a moderate 1.2% increase in profit attributable to owners. No changes have been made to the most recently announced forecast for dividends, which is set at 90 yen for the fiscal year ending March 31, 2025.
For further insights into JP:4547 stock, check out TipRanks’ Stock Analysis page.